Marketing-authorisation holder · United States
Pharmacia & Upjohn Company LLC
64 medicines in 1 country, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
64 medicines in 1 country, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 64
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADRUCIL50MG/ML | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Fluorouracil | United States | Not marketed | 1991 |
| ALBAMYCIN250mg base · Capsule | Novobiocin | United States | Not marketed | 1964 |
| ALPHADROL1.5mg · Tablet | Fluprednisolone | United States | Not marketed | |
| ANSAID100mg | 50mg · Tablet | Flurbiprofen | United States | Not marketed | 1988 |
| Atgam50mg/ml · Injection | Lymphocyte immune globulin, anti-thymocyte globulin | United States | Marketed | 1996 |
| AZULFIDINE250mg/5ml · Suspension | Sulfasalazine | United States | Not marketed | 1980 |
| BACIGUENT500 units/gm · Ointment | Bacitracin | United States | Not marketed | 1948 |
| BERUBIGEN1mg/ml · Injectable | Vitamin b12 | United States | Not marketed | |
| CALMURID HC1%; 10% · Cream | Hydrocortisone, Carbamide | United States | Not marketed | |
| CARDRASE125mg | 62.5mg · Tablet | Ethoxzolamide | United States | Not marketed | |
| CLEOCIN150mg base | 75mg base · Capsule | Clindamycin | United States | Not marketed | |
| CORTEF10mg | 20mg | 5mg · Tablet | Hydrocortisone | United States | Marketed | 1952 |
| CORTEF10mg base/5ml · Suspension | Hydrocortisone cypionate | United States | Not marketed | 1955 |
| CORTEF50mg/ml · Injectable | Hydrocortisone | United States | Not marketed | |
| CORTEF ACETATE50mg/ml · Injectable | Hydrocortisone | United States | Not marketed | |
| CORTEF ACETATE1% | 2.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Ointment | Hydrocortisone | United States | Not marketed | 1953 |
| CYKLOKAPRON500mg · Tablet | Tranexamic acid | United States | Not marketed | 1986 |
| DELTA-CORTEF5MG · Tablet | Prednisolone | United States | Not marketed | 1955 |
| DELTASONE10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG **Federal Register · Tablet | Prednisone | United States | Not marketed | 1955 |
| DEPO-TESTADIOL2mg/ml; 50mg/ml · Injectable | Estradiol cypionate, Testosterone | United States | Not marketed | 1980 |
| DIZAC5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Diazepam | United States | Not marketed | |
| E-MYCIN E200mg base/5ml | 400mg base/5ml · Suspension | Erythromycin | United States | Not marketed | |
| EMCYT140mg phosphate · Capsule | Estramustine | United States | Not marketed | 1981 |
| FEMINONE0.05mg · Tablet | Ethinyl estradiol | United States | Not marketed | |
| FLUIDIL2MG · Tablet | Cyclothiazide | United States | Not marketed |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 64 | 64 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.